La Jolla, CA4 Active Studies

Endometrial Cancer Clinical Trials in La Jolla, CA

Find 4 actively recruiting endometrial cancer clinical trials in La Jolla, CA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
1,633
Enrolling

Recruiting Endometrial Cancer Studies in La Jolla

RecruitingLa Jolla, CANCT06486441

Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)

The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer who have received prior treatment with platinum-based chemot...

640 participants
Gilead Sciences
View Study Details
RecruitingLa Jolla, CANCT06989112

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when compared to chemotherapy (carboplatin + paclitaxel) + pembroliz...

600 participants
AstraZeneca
View Study Details
RecruitingLa Jolla, CANCT05548296

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

This is an open label Phase 2 study to evaluate the efficacy and safety of ACR-368 as monotherapy or with ultra-low dose gemcitabine (ULDG) sensitization in participants with endometrial cancer....

353 participants
Acrivon Therapeutics
View Study Details
RecruitingLa Jolla, CANCT06463028

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

This is a Phase 2, multicenter, open-label, single-arm study to evaluate the efficacy and safety of sapanisertib and serabelisib (PIKTOR) with paclitaxel in participants with advanced or recurrent end...

40 participants
Faeth Therapeutics
View Study Details

About Endometrial Cancer Clinical Trials in La Jolla

Endometrial cancer begins in the lining of the uterus and is the most common gynecologic cancer. It is often detected early due to abnormal bleeding symptoms. Treatment typically involves surgery, with radiation, chemotherapy, or hormone therapy for advanced cases.

There are currently 4 endometrial cancer clinical trials recruiting participants in La Jolla, CA. These studies are seeking a combined 1,633 participants. Research is being sponsored by Gilead Sciences, AstraZeneca, Acrivon Therapeutics and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Endometrial Cancer Clinical Trials in La Jolla — FAQ

Are there endometrial cancer clinical trials in La Jolla?

Yes, there are 4 endometrial cancer clinical trials currently recruiting in La Jolla, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in La Jolla?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the La Jolla research site will contact you about next steps.

Are clinical trials in La Jolla free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many La Jolla studies also compensate for your time and travel.

What endometrial cancer treatments are being tested?

The 4 active trials in La Jolla are testing new therapies including novel drugs, biologics, and treatment approaches for endometrial cancer.

Data updated March 2, 2026 from ClinicalTrials.gov